| 1 |
Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis[J]. Nat Rev Dis Primers, 2019, 5(1): 16.
|
| 2 |
Jouneau S, Chauvin P, Lederlin M, et al. Pharmacotherapy for autoimmune pulmonary alveolar proteinosis[J]. Drugs, 2025, 85(10): 1193-1206.
|
| 3 |
Bonfield TL, Raychaudhuri B, Malur A, et al. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor[J]. Am J Physiol Lung Cell Mol Physiol, 2003, 285(5): L1132-1136.
|
| 4 |
Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan[J]. Am J Respir Crit Care Med, 2008, 177(7): 752-762.
|
| 5 |
Holbert JM, Costello P, Li W, et al. CT features of pulmonary alveolar proteinosis[J]. AJR Am J Roentgenol, 2001, 176(5): 1287-1294.
|
| 6 |
Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease[J]. Eur Respir Rev, 2010, 19(117): 237-241.
|
| 7 |
Mccarthy C, Bonella F, O′Callaghan M, et al. European respiratory society guidelines for the diagnosis and management of pulmonary alveolar proteinosis[J]. Eur Respir J, 2024, 64(5): 2400725.
|
| 8 |
Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease[J]. Annu Rev Med, 2010, 61: 105-119.
|
| 9 |
Harari S, Caminati A. Update on diffuse parenchymal lung disease[J]. Eur Respir Rev, 2010, 19(116): 97-108.
|
| 10 |
Ferretti A, Fortwendel JR, Gebb SA, et al. Autoantibody-mediated pulmonary alveolar proteinosis in Rasgrp1-deficient mice[J]. J Immunol, 2016, 197(2): 470-479.
|
| 11 |
Uchida K, Nakata K, Carey B, et al. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis[J]. J Immunol Methods, 2014, 402(1-2): 57-70.
|
| 12 |
Johkoh T, Itoh H, Müller NL, et al. Crazy-paving appearance at thin-section CT: Spectrum of disease and pathologic findings[J]. Radiology, 1999, 211(1): 155-160.
|
| 13 |
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: Progress in the first 44 years[J]. Am J Respir Crit Care Med, 2002, 166(2): 215-235.
|
| 14 |
McCarthy C, Carey B, Trapnell BC. Blood testing for differential diagnosis of pulmonary alveolar proteinosis syndrome[J]. Chest, 2019, 155(2): 450-452.
|
| 15 |
Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis[J]. Am J Respir Crit Care Med, 2000, 162(2 Pt 1): 658-662.
|
| 16 |
Uchida K, Nakata K, Suzuki T, et al. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects[J]. Blood, 2009, 113(11): 2547-2556.
|
| 17 |
Kusakabe Y, Uchida K, Hiruma T, et al. A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry[J]. J Immunol Methods, 2014, 413: 1-11.
|
| 18 |
Gay P, Wallaert B, Nowak S, et al. Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: a multicenter international study of GELF[J]. Respiration, 2017, 93(3): 198-206.
|
| 19 |
Awab A, Khan MS, Youness HA. Whole lung lavage-technical details, challenges and management of complications[J]. J Thorac Dis, 2017, 9(6): 1697-1706.
|
| 20 |
Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for pulmonary alveolar proteinosis[J]. N Engl J Med, 2019, 381(10): 923-932.
|